Now, a pill that comes with a plan.
Get the full picture in OAB care

Toviaz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency

Fesoterodine (INN, brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome. It was approved by the European Medicines Agency in April 2007 and was approved by the US Food and Drug Administration on October 31, 2008.

Fesoterodine is a prodrug. It is broken down into its active metabolite, 5-hydroxymethyl tolterodine, by plasma esterases.

More on Wikipedia

Brand name: Toviaz
Generic name/category: Fesoterodine, Muscarinic antagonists, Prodrugs
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Overactive bladder OAB
Target: Healthcare Professionals (HCP)
Tagline: Get the full picture in OAB care
Medium: Print ad
Size/duration: single-page
Publication/Aired: Urology Times – September 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 07, 2009

Visit AdPharm.net for more pharmaceutical ads